Sabra Healthcare REIT (SBRA) had its price target raised by Wells Fargo & Company from $21.00 to $22.00. They now have an "overweight" rating on the stock.
Sabra Healthcare REIT (SBRA) was upgraded by
Weiss Ratings from "buy (b+)" to "buy (a-)".
Sabra Health Care REIT, Inc. to Attend the 2026 NIC Spring Conference
Engineers Gate Trims Sabra Health Care REIT Stake as Investors Track Rental Income Trends [Yahoo! Finance]
Sabra Healthcare REIT (SBRA) had its price target raised by Truist Financial Corporation from $21.00 to $22.00. They now have a "hold" rating on the stock.